Eagle Pharmaceuticals (EGRX) Financials

$0.75

$-0.18 (-18.92%)

As on 04-Sep-2026 09:30EDT

Market cap

$3 Mln

Revenue (TTM)

$258 Mln

P/E Ratio

1.3

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	257.55	316.61	171.55	187.80	195.89	213.31
Cost of Revenue	77.68	94.94	42.18	45.47	60.90	61.92
Gross Profit	179.88	221.67	129.37	142.34	135.00	151.40
Operating Expenses	138.87	140.71	126.60	109.38	113.18	104.93
Operating Profit (EBIT)	23.65	80.96	2.77	32.95	21.82	36.62
Other Income	-5.74	-15.48	-5.68	-7.70	2.87	0.16
Profit before Tax	32.79	61.43	-4.55	22.68	22.00	34.04
Provision for Tax	17.22	25.79	4.08	10.69	7.69	2.14
Profit after Tax (Net Income)	15.57	35.64	-8.63	11.99	14.31	31.90
Minority Interest	--	--	--	--	--	--
Consolidated Profit	15.57	35.64	-8.63	11.99	14.31	31.90

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	252.04	233.56	176.45	186.01	179.17	160.76
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	66.15	61.51	2.90	29.09	36.56	38.16
Current Liabilities	86.63	111.09	74.38	38.09	38.82	39.69
Total Liabilities	491.45	406.16	253.73	253.19	254.55	238.60

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	217.57	217.41	81.13	87.13	75.11	74.76
Current Assets	187.25	188.75	172.61	166.07	179.45	163.84
Total Assets	491.45	406.16	253.73	253.19	254.55	238.60
Total Debt*	71.62	67.79	29.82	38.22	38.56	44.41
Net Current Assets	100.62	77.67	98.23	127.98	140.63	124.16

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	30.80	28.22	49.50	55.99	52.38
Cash Flow from Investing Activities	--	-86.83	-5.32	-18.25	-0.78	-0.13
Cash from Financing Activities	--	-6.21	-28.39	-37.87	-24.23	-88.12
Net Cash Inflow / Outflow	--	-42.34	-5.50	-6.62	30.98	-35.87

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	1.19	2.72	-0.67	0.87	1.01	2.17
Cash EPS ($)	0.20	3.63	-0.38	1.22	1.34	2.42
Adjusted Book Value ($)	19.25	17.80	13.68	13.51	12.69	10.95
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	2.35	2.19	3.59	3.96	3.57
Free Cash Flow per Share ($)	--	2.35	2.16	3.54	3.91	3.56

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	14.04	-4.01	5.43	6.77	14.77
ROE (%)	-83.45	17.39	-4.76	6.57	8.42	18.77
ROA (%)	3.17	10.80	-3.40	4.72	5.80	12.54
EBIT Margin (%)	13.72	20.68	-1.70	13.45	12.60	17.24
Net Margin (%)	6.18	11.84	-5.20	6.66	7.20	14.94
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	-5.38	0.85	-0.09	-0.04	-0.08	-0.10
EBIT Growth (%)	-26.31	2,347.79	-111.53	2.31	-32.88	-50.36
Net Profit Growth (%)	-803.13	513.14	-171.96	-16.24	-55.14	-38.58
EPS Growth (%)	-32.93	5.06	-1.77	-0.14	-0.53	-0.35
Book Value Growth (%)	3.34	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	1.25	10.76	-76.12	53.49	59.27	18.55
Price / Book Value	0.16	1.64	3.72	3.45	4.74	3.68
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.75	5.11	689.34	19.20	26.49	13.78
Close Price ($)	19.44	29.23	50.92	46.57	60.08	40.29
High Price ($)	47.71	53.78	58.25	60.67	64.94	85.66
Low Price ($)	17.68	24.35	36.48	33.80	38.38	36.03
Market Cap ($ Cr)	3.29	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	0.25	0.29	0.17	0.21	0.22	0.28
Short term debt to equity ratio	0.04	0.03	0.15	0.05	0.03	0.04
Current Ratio	2.16	1.70	2.32	4.36	4.62	4.13
Quick Ratio	1.67	1.27	2.03	4.15	4.45	3.92
Interest Coverage	6.02	16.19	-1.78	9.80	9.19	13.44

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	45.15	23.20	24.19	27.22	24.51	31.17
Asset Turnover	0.52	0.96	0.68	0.74	0.79	0.84
Receivable days	--	66.30	98.59	96.39	106.74	103.00
Inventory Days	--	134.08	129.82	58.81	44.59	39.59
Payable days	--	68.14	98.28	47.12	46.12	64.59
Cash Conversion Cycle	--	132.24	130.13	108.08	105.21	78.00

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.